Evidence map›Paper›PMID 36794683›Full record

Observational studyThe journal of vascular access2024

Octyl-butyl-cyanoacrylate glue for securement of peripheral intravenous catheters: A retrospective, observational study in the neonatal population.

Matheus Fpt van Rens, Timothy R Spencer, Kevin Hugill, Airene Lv Francia, Fredericus Hj van Loon, Mohammad Aa Bayoumi

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in The journal of vascular access, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Matheus Fpt van RensWomen's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.ORCID 0000-0002-9595-0265
Timothy R SpencerGlobal Vascular Access LLC, Scottsdale, AZ, USA.ORCID 0000-0002-3128-2034
Kevin HugillDepartment of Nursing and Midwifery Education, Hamad Medical Corporation, Doha, Qatar.
Airene Lv FranciaWomen's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.
Fredericus Hj van LoonAnesthesiology, Intensive Care and Pain Medicine, Catharina Hospital, Eindhoven, The Netherlands.ORCID 0000-0003-3854-6976
Mohammad Aa BayoumiWomen's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.ORCID 0000-0002-2627-4806
Hamad Medical Corporation · QARadboud University Nijmegen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEvidence-based insertion and maintenance strategies for neonatal vascular access devices (VAD) exist to reduce the causes of VAD failure and complications in neonates. Peripheral intravenous catheter failure and complications including, infiltration, extravasation, phlebitis, dislodgement with/without removal, and infection are majorly influenced by catheter securement methods.

methodsA retrospective, observational study using routinely collected data on intravenous device use in a large neonatal intensive care unit in Qatar. A 6-month historical cohort was compared with a 6-month cohort after the introduction of an octyl-butyl-cyanoacrylate glue (CG). In the historical cohort, the catheter was secured using a semi-permeable transparent membrane dressing while in the CG cohort, CG was applied at the insertion site on initial insertion and after any dressing change. This was the only variable intervention between both groups.

resultsA total of 8330 peripheral catheters were inserted. All catheters were inserted and monitored by members of the NeoVAT team. 4457 (53.5%) were secured with just a semi-permeable transparent dressing and 3873 (46.5%) secured a semi-permeable transparent dressing with the addition of CG. The odds ratio for premature failure after securement with CG was 0.59 (0.54-0.65) when compared to the catheters secured with a semi-permeable transparent dressing, which was statistically significant (

conclusionsThe risk of developing device-related phlebitis and premature device removal, increased significantly if CG was not used for adjunct catheter securement. In parallel with the currently published literature, this study's findings support the use of CG for vascular device securement. When device securement and stabilization concerns are most pertinent CG is a safe and effective adjunct to reducing therapy failures in the neonatal patient population.

Indexed as

Catheterization, PeripheralCatheters, IndwellingEnbucrilateTissue AdhesivesFemaleHumansInfant, NewbornIntensive Care Units, NeonatalMaleQatarRetrospective StudiesRisk FactorsTime FactorsTreatment OutcomeEnbucrilateTissue Adhesivescomplicationscyanoacrylateinfection preventionNeonateperipheral intravenous devicesvascular access

Identifiers

PMID36794683
PMCPMC11308324
OpenAlexW4321004281

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.